• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型和 2 型肌强直性营养不良患者的身体成分分析。

Body composition analysis in patients with myotonic dystrophy types 1 and 2.

机构信息

Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, 6, Dr. Subotic Street, Belgrade, 11000, Serbia.

Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Dr Subotica starijeg 13, Belgrade, Serbia.

出版信息

Neurol Sci. 2019 May;40(5):1035-1040. doi: 10.1007/s10072-019-03763-0. Epub 2019 Feb 21.

DOI:10.1007/s10072-019-03763-0
PMID:30790082
Abstract

INTRODUCTION

To date, there are only several reports on body composition in myotonic dystrophy type 1 (DM1) and there are no data for myotonic dystrophy type 2 (DM2). The aim was to analyze body composition of patients with DM1 and DM2, and its association with socio-demographic and clinical features of the diseases.

METHODS

There were no statistical differences in sociodemographic features between 20 DM1 patients and 12 DM2 patients. Body composition was assessed by DEXA (dual-energy x-ray absorptiometry). A three-compartment model was used: bone mineral content (BMC), fat mass (FM), and lean tissue mass (LTM).

RESULTS

Patients with DM1 and DM2 had similar total body mass (TBM), BMC, FM, and LTM. Patients with DM1 had higher trunk-limb fat index (TLFI) in comparison to DM2 patients which indicates visceral fat deposition in DM1 (1.16 ± 0.32 for DM1 vs. 0.87 ± 0.23 for DM2, p < 0.05). Right ribs bone mineral density was lower in DM2 group (0.68 ± 0.07 g/cm vs. 0.61 ± 0.09 g/cm, p < 0.05). Higher percentage of FM in legs showed correlation with lower strength of the upper leg muscles in DM1 (ρ = - 0.47, p < 0.05). Higher muscle strength in DM2 patients was in correlation with higher bone mineral density (ρ = + 0.62, p < 0.05 for upper arm muscles, ρ = + 0.87, p < 0.01 for lower arm muscles, ρ = + 0.72, p < 0.05 for lower leg muscles).

CONCLUSION

DM1 patients had visceral obesity, and percentage of FM correlated with a degree of muscle weakness in upper legs. In DM2 patients, degree of muscle weakness was in correlation with higher FM index and lower bone mineral density.

摘要

简介

迄今为止,仅有少数关于 1 型肌强直性营养不良(DM1)患者身体成分的报告,而 2 型肌强直性营养不良(DM2)患者的相关数据则没有。本研究旨在分析 DM1 和 DM2 患者的身体成分,并探讨其与疾病的社会人口统计学和临床特征的关系。

方法

20 名 DM1 患者和 12 名 DM2 患者在社会人口统计学特征方面无统计学差异。通过 DEXA(双能 X 线吸收法)评估身体成分。使用三腔模型:骨矿物质含量(BMC)、脂肪量(FM)和瘦组织量(LTM)。

结果

DM1 和 DM2 患者的总体重(TBM)、BMC、FM 和 LTM 相似。与 DM2 患者相比,DM1 患者的躯干-肢体脂肪指数(TLFI)更高,这表明 DM1 患者存在内脏脂肪沉积(1.16±0.32 对 0.87±0.23,p<0.05)。DM2 组右侧肋骨骨密度较低(0.68±0.07 g/cm 对 0.61±0.09 g/cm,p<0.05)。DM1 患者腿部 FM 百分比较高与大腿肌肉力量较低呈负相关(ρ=-0.47,p<0.05)。DM2 患者肌肉力量较高与骨矿物质密度较高呈正相关(ρ=+0.62,p<0.05 为上臂肌肉,ρ=+0.87,p<0.01 为前臂肌肉,ρ=+0.72,p<0.05 为小腿肌肉)。

结论

DM1 患者存在内脏肥胖,FM 百分比与大腿肌肉无力程度相关。在 DM2 患者中,肌肉无力程度与较高的 FM 指数和较低的骨矿物质密度相关。

相似文献

1
Body composition analysis in patients with myotonic dystrophy types 1 and 2.1 型和 2 型肌强直性营养不良患者的身体成分分析。
Neurol Sci. 2019 May;40(5):1035-1040. doi: 10.1007/s10072-019-03763-0. Epub 2019 Feb 21.
2
MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.1型强直性肌营养不良患者躯干肌肉的磁共振成像以及运动和呼吸功能
BMC Neurol. 2019 Jun 19;19(1):135. doi: 10.1186/s12883-019-1357-8.
3
Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.1型和2型强直性肌营养不良中强直性放电的严重程度、类型及分布有所不同。
Muscle Nerve. 2007 Apr;35(4):479-85. doi: 10.1002/mus.20722.
4
Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.肌肉骨骼系统磁共振成像。
J Neurol. 2017 Sep;264(9):1899-1908. doi: 10.1007/s00415-017-8574-0. Epub 2017 Jul 29.
5
Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.1型和2型强直性肌营养不良症不同的神经肌肉表型:一项全身高场磁共振成像研究
J Neurol. 2006 Jun;253(6):753-61. doi: 10.1007/s00415-006-0111-5. Epub 2006 Mar 6.
6
Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies.1型和2型强直性肌营养不良男性患者循环中的鸢尾素水平降低。
Front Endocrinol (Lausanne). 2017 Nov 14;8:320. doi: 10.3389/fendo.2017.00320. eCollection 2017.
7
Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.强直性肌营养不良的肌肉病理学:18例患者的光镜和电镜研究
Folia Morphol (Warsz). 2011 May;70(2):121-9.
8
Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.肌强直性营养不良 2 型的骨骼肌受累。一项肌肉超声比较研究。
Neuromuscul Disord. 2012 Jun;22(6):492-9. doi: 10.1016/j.nmd.2012.01.006. Epub 2012 Mar 11.
9
Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1.1 型肌强直性营养不良患者的能量消耗、身体成分和骨骼肌氧化能力。
J Neuromuscul Dis. 2023;10(4):701-712. doi: 10.3233/JND-230036.
10
Regional body composition and functional impairment in patients with myotonic dystrophy.肌强直性营养不良患者的区域性身体成分和功能障碍。
Muscle Nerve. 2011 Oct;44(4):503-8. doi: 10.1002/mus.22099. Epub 2011 Aug 8.

引用本文的文献

1
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1.肌肉特异性基因编辑改善了1型强直性肌营养不良小鼠模型中的分子和表型缺陷。
Clin Transl Med. 2025 Feb;15(2):e70227. doi: 10.1002/ctm2.70227.
2
Skeletal muscle disorders as risk factors for type 2 diabetes.骨骼肌疾病作为2型糖尿病的风险因素。
Mol Cell Endocrinol. 2025 Apr 1;599:112466. doi: 10.1016/j.mce.2025.112466. Epub 2025 Jan 21.
3
Common Characteristics Between Frailty and Myotonic Dystrophy Type 1: A Narrative Review.

本文引用的文献

1
Editorial: Beyond Borders: Myotonic Dystrophies-A European Perception.社论:超越国界:强直性肌营养不良症——欧洲视角
Front Neurol. 2018 Sep 20;9:787. doi: 10.3389/fneur.2018.00787. eCollection 2018.
2
Myotonic Dystrophy Type 2 - Data from the Serbian Registry.肌强直性营养不良 2 型 - 来自塞尔维亚登记处的数据。
J Neuromuscul Dis. 2018;5(4):461-469. doi: 10.3233/JND-180328.
3
Core Clinical Phenotypes in Myotonic Dystrophies.强直性肌营养不良的核心临床表型
脆弱与1型强直性肌营养不良之间的共同特征:一篇叙述性综述。
Aging Dis. 2024 Aug 29;16(4):2120-2131. doi: 10.14336/AD.2024.0950.
4
Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1.1 型肌强直性营养不良患者的能量消耗、身体成分和骨骼肌氧化能力。
J Neuromuscul Dis. 2023;10(4):701-712. doi: 10.3233/JND-230036.
5
Safety and immunogenicity of mRNA COVID-19 vaccine in inpatients with muscular dystrophy.mRNA COVID-19 疫苗在肌肉疾病住院患者中的安全性和免疫原性。
Muscle Nerve. 2023 Feb;67(2):117-123. doi: 10.1002/mus.27761. Epub 2022 Dec 19.
6
Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.肢带型肌营养不良症 2B 型导致患者高密度脂蛋白胆固醇异常,以及肌营养不良蛋白缺陷型小鼠出现他汀类药物抵抗性肌肉消耗。
Skelet Muscle. 2022 Nov 29;12(1):25. doi: 10.1186/s13395-022-00308-6.
7
Assessment of body composition, metabolism, and pulmonary function in patients with myotonic dystrophy type 1.评估 1 型肌强直性营养不良患者的身体成分、代谢和肺功能。
Medicine (Baltimore). 2022 Sep 9;101(36):e30412. doi: 10.1097/MD.0000000000030153.
8
Late-onset neuromuscular disorders in the differential diagnosis of sarcopenia.少肌症鉴别诊断中的迟发性神经肌肉疾病
BMC Neurol. 2021 Jun 25;21(1):241. doi: 10.1186/s12883-021-02264-y.
9
Myotonic dystrophy type 2: the 2020 update.肌强直性营养不良 2 型:2020 更新版。
Acta Myol. 2020 Dec 1;39(4):222-234. doi: 10.36185/2532-1900-026. eCollection 2020 Dec.
10
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?1 型肌强直性营养不良是否为 COVID-19 重症的一个主要危险因素?
Acta Neurol Belg. 2021 Dec;121(6):1761-1765. doi: 10.1007/s13760-020-01514-z. Epub 2020 Oct 14.
Front Neurol. 2018 May 2;9:303. doi: 10.3389/fneur.2018.00303. eCollection 2018.
4
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle.受体及受体后异常导致1型和2型强直性肌营养不良症骨骼肌中的胰岛素抵抗。
PLoS One. 2017 Sep 15;12(9):e0184987. doi: 10.1371/journal.pone.0184987. eCollection 2017.
5
Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.肌肉骨骼系统磁共振成像。
J Neurol. 2017 Sep;264(9):1899-1908. doi: 10.1007/s00415-017-8574-0. Epub 2017 Jul 29.
6
Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.1型强直性肌营养不良患者的身体成分和临床结局指标
Neuromuscul Disord. 2017 Mar;27(3):286-289. doi: 10.1016/j.nmd.2016.11.005. Epub 2016 Nov 16.
7
Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - A cross sectional survey.遗传性肌病和散发性包涵体肌炎中骨质疏松、跌倒和骨折的危险因素——一项横断面调查。
Mol Genet Metab Rep. 2014 Feb 11;1:85-97. doi: 10.1016/j.ymgmr.2013.12.005. eCollection 2014.
8
Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1.超重是1型强直性肌营养不良症患者肺容积降低的独立危险因素。
PLoS One. 2016 Mar 25;11(3):e0152344. doi: 10.1371/journal.pone.0152344. eCollection 2016.
9
Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.性别作为影响1型强直性肌营养不良症表型严重程度和死亡率的修饰因素:一项全国多数据库横断面观察性研究。
PLoS One. 2016 Feb 5;11(2):e0148264. doi: 10.1371/journal.pone.0148264. eCollection 2016.
10
Variability of multisystemic features in myotonic dystrophy type 1--lessons from Serbian registry.1型强直性肌营养不良多系统特征的变异性——来自塞尔维亚登记处的经验教训
Neurol Res. 2015 Nov;37(11):939-44. doi: 10.1179/1743132815Y.0000000068. Epub 2015 Jul 17.